Prasad Raju bought CRSP

January 22, 2026 · Form 4 insider transaction

Prasad Raju bought 34,972 shares of CRISPR Therapeutics AG at $45.15 per share, a transaction worth $1.58M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.